DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $841,152 | -8.5% | 3,636 | -1.9% | 0.19% | -15.9% |
| Q3 2023 | $919,459 | +3.4% | 3,706 | 0.0% | 0.23% | +7.1% |
| Q2 2023 | $889,440 | -4.8% | 3,706 | 0.0% | 0.21% | -6.6% |
| Q1 2023 | $934,060 | +89886.5% | 3,706 | -5.2% | 0.23% | -12.7% |
| Q4 2022 | $1,038 | -99.9% | 3,910 | -2.5% | 0.26% | +0.8% |
| Q3 2022 | $1,036,000 | -0.7% | 4,010 | -2.5% | 0.26% | +6.2% |
| Q2 2022 | $1,043,000 | -13.6% | 4,114 | 0.0% | 0.24% | +9.0% |
| Q1 2022 | $1,207,000 | -14.0% | 4,114 | -3.5% | 0.22% | -10.1% |
| Q4 2021 | $1,403,000 | +1.0% | 4,264 | -6.6% | 0.25% | -5.3% |
| Q3 2021 | $1,389,000 | +9.4% | 4,564 | -3.6% | 0.26% | +9.6% |
| Q2 2021 | $1,270,000 | +19.1% | 4,732 | -0.1% | 0.24% | +12.2% |
| Q1 2021 | $1,066,000 | +5.8% | 4,736 | +4.4% | 0.21% | +1.4% |
| Q4 2020 | $1,008,000 | +3.8% | 4,536 | +0.6% | 0.21% | -9.5% |
| Q3 2020 | $971,000 | +19.1% | 4,508 | -2.2% | 0.23% | +10.0% |
| Q2 2020 | $815,000 | +21.3% | 4,608 | -5.1% | 0.21% | +3.9% |
| Q1 2020 | $672,000 | -6.7% | 4,858 | +3.6% | 0.20% | +18.7% |
| Q4 2019 | $720,000 | +6.4% | 4,690 | 0.0% | 0.17% | -1.7% |
| Q3 2019 | $677,000 | +1.0% | 4,690 | 0.0% | 0.17% | -1.1% |
| Q2 2019 | $670,000 | -6.7% | 4,690 | -13.8% | 0.18% | -9.7% |
| Q1 2019 | $718,000 | +26.9% | 5,440 | -0.9% | 0.20% | +15.4% |
| Q4 2018 | $566,000 | -5.2% | 5,490 | 0.0% | 0.17% | +8.3% |
| Q3 2018 | $597,000 | +10.1% | 5,490 | 0.0% | 0.16% | +4.0% |
| Q2 2018 | $542,000 | +0.7% | 5,490 | 0.0% | 0.15% | -1.3% |
| Q1 2018 | $538,000 | +111.0% | 5,490 | +100.0% | 0.15% | +7.8% |
| Q4 2017 | $255,000 | -45.9% | 2,745 | -50.0% | 0.14% | +3.7% |
| Q3 2017 | $471,000 | +103.0% | 5,490 | +100.0% | 0.14% | -2.2% |
| Q2 2017 | $232,000 | -2.9% | 2,745 | -1.8% | 0.14% | -5.4% |
| Q1 2017 | $239,000 | +11.7% | 2,795 | +1.8% | 0.15% | +8.9% |
| Q4 2016 | $214,000 | -52.2% | 2,745 | -38.2% | 0.14% | -10.0% |
| Q2 2016 | $448,000 | +6.4% | 4,440 | 0.0% | 0.15% | +6.4% |
| Q1 2016 | $421,000 | -3.2% | 4,440 | -5.1% | 0.14% | -5.4% |
| Q4 2015 | $435,000 | +117.5% | 4,680 | +100.0% | 0.15% | +12.0% |
| Q2 2015 | $200,000 | -5.2% | 2,340 | -6.0% | 0.13% | -6.3% |
| Q1 2015 | $211,000 | -0.9% | 2,490 | 0.0% | 0.14% | -13.4% |
| Q4 2014 | $213,000 | +3.4% | 2,490 | -5.0% | 0.16% | +3.8% |
| Q2 2014 | $206,000 | -7.2% | 2,620 | -11.5% | 0.16% | -12.7% |
| Q1 2014 | $222,000 | – | 2,959 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |